APO Research
Talk to an analyst

APO RESEARCH · REPORT

High Purity Pharmaceutical Excipient

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global High Purity Pharmaceutical Excipient Industry Growth and Trends Forecast to 2032

24 December 202597 pages

Choose your research edition.

Industry ResearchHigh Purity Pharmaceutical Excipient Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal High Purity Pharmaceutical Excipient Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal High Purity Pharmaceutical Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High Purity Pharmaceutical Excipient Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal High Purity Pharmaceutical Excipient Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global High Purity Pharmaceutical Excipient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for High Purity Pharmaceutical Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for High Purity Pharmaceutical Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High Purity Pharmaceutical Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of High Purity Pharmaceutical Excipient include Evonik, BASF, Syensqo, Mitsubishi, JRS Pharma, Croda Pharma, Ashland, Roquette and Seqens, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global High Purity Pharmaceutical Excipient market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The High Purity Pharmaceutical Excipient market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global High Purity Pharmaceutical Excipient market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to High Purity Pharmaceutical Excipient.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global High Purity Pharmaceutical Excipient market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

High Purity Pharmaceutical Excipient Market by Company

Evonik

BASF

Syensqo

Mitsubishi

JRS Pharma

Croda Pharma

Ashland

Roquette

Seqens

High Purity Pharmaceutical Excipient Segment by Type

Natural Excipients

Semi-natural Excipients

Completely Synthetic Excipients

High Purity Pharmaceutical Excipient Segment by Application

Injectable Medications

Ocular Medications

Oral Medications

Medications Inhaled Through the Nose or Mouth

Others

High Purity Pharmaceutical Excipient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Purity Pharmaceutical Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High Purity Pharmaceutical Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Purity Pharmaceutical Excipient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of High Purity Pharmaceutical Excipient manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of High Purity Pharmaceutical Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natural Excipients Table 2. Major Company of Semi-natural Excipients Table 3. Major Company of Completely Synthetic Excipients Table 4. Global High Purity Pharmaceutical Excipient Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 6. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type (2021-2026) Table 7. Global High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 8. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Type (2021-2026) Table 9. Global High Purity Pharmaceutical Excipient Price by Type (2021-2026) & (US$/Ton) Table 10. Global High Purity Pharmaceutical Excipient Sales by Type (2027-2032) & (Tons) Table 11. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type (2027-2032) Table 12. Global High Purity Pharmaceutical Excipient Sales by Type (2027-2032) & (US$ Million) Table 13. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Type (2027-2032) Table 14. Global High Purity Pharmaceutical Excipient Price by Type (2027-2032) & (US$/Ton) Table 15. North America High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 16. North America High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 17. Europe High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 18. Europe High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 22. Latin America High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Type (2021-2026) & (US$ Million) Table 25. High Purity Pharmaceutical Excipient Industry Trends Table 26. High Purity Pharmaceutical Excipient Industry Drivers Table 27. High Purity Pharmaceutical Excipient Industry Opportunities and Challenges Table 28. High Purity Pharmaceutical Excipient Industry Restraints Table 29. Global High Purity Pharmaceutical Excipient Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global High Purity Pharmaceutical Excipient Revenue Market Share by Company (2021-2026) Table 31. Global High Purity Pharmaceutical Excipient Sales by Company (2021-2026) & (Tons) Table 32. Global High Purity Pharmaceutical Excipient Sales Share by Company (2021-2026) Table 33. Global High Purity Pharmaceutical Excipient Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global High Purity Pharmaceutical Excipient Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global High Purity Pharmaceutical Excipient Major Company Production Sites and Headquarters Table 36. Global High Purity Pharmaceutical Excipient Company, Product Type & Application Table 37. Global High Purity Pharmaceutical Excipient Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global High Purity Pharmaceutical Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global High Purity Pharmaceutical Excipient Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global High Purity Pharmaceutical Excipient Sales by Region (2021-2026) & (Tons) Table 42. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Region (2021-2026) Table 43. Global High Purity Pharmaceutical Excipient Sales by Region (2021-2026) & (US$ Million) Table 44. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Region (2021-2026) Table 45. Global High Purity Pharmaceutical Excipient Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global High Purity Pharmaceutical Excipient Sales by Region (2027-2032) & (Tons) Table 47. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Region (2027-2032) Table 48. Global High Purity Pharmaceutical Excipient Sales by Region (2027-2032) & (US$ Million) Table 49. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Region (2027-2032) Table 50. Global High Purity Pharmaceutical Excipient Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global High Purity Pharmaceutical Excipient Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 53. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application (2021-2026) Table 54. Global High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 55. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Application (2021-2026) Table 56. Global High Purity Pharmaceutical Excipient Price by Application (2021-2026) & (US$/Ton) Table 57. Global High Purity Pharmaceutical Excipient Sales by Application (2027-2032) & (Tons) Table 58. Global High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application (2027-2032) Table 59. Global High Purity Pharmaceutical Excipient Sales by Application (2027-2032) & (US$ Million) Table 60. Global High Purity Pharmaceutical Excipient Sales Market Share in Value by Application (2027-2032) Table 61. Global High Purity Pharmaceutical Excipient Price by Application (2027-2032) & (US$/Ton) Table 62. North America High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 63. North America High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 64. Europe High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 65. Europe High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 69. Latin America High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Application (2021-2026) & (US$ Million) Table 72. Evonik Company Information Table 73. Evonik Business Overview Table 74. Evonik High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Evonik High Purity Pharmaceutical Excipient Product Portfolio Table 76. Evonik Recent Development Table 77. BASF Company Information Table 78. BASF Business Overview Table 79. BASF High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. BASF High Purity Pharmaceutical Excipient Product Portfolio Table 81. BASF Recent Development Table 82. Syensqo Company Information Table 83. Syensqo Business Overview Table 84. Syensqo High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Syensqo High Purity Pharmaceutical Excipient Product Portfolio Table 86. Syensqo Recent Development Table 87. Mitsubishi Company Information Table 88. Mitsubishi Business Overview Table 89. Mitsubishi High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Mitsubishi High Purity Pharmaceutical Excipient Product Portfolio Table 91. Mitsubishi Recent Development Table 92. JRS Pharma Company Information Table 93. JRS Pharma Business Overview Table 94. JRS Pharma High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. JRS Pharma High Purity Pharmaceutical Excipient Product Portfolio Table 96. JRS Pharma Recent Development Table 97. Croda Pharma Company Information Table 98. Croda Pharma Business Overview Table 99. Croda Pharma High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Croda Pharma High Purity Pharmaceutical Excipient Product Portfolio Table 101. Croda Pharma Recent Development Table 102. Ashland Company Information Table 103. Ashland Business Overview Table 104. Ashland High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Ashland High Purity Pharmaceutical Excipient Product Portfolio Table 106. Ashland Recent Development Table 107. Roquette Company Information Table 108. Roquette Business Overview Table 109. Roquette High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Roquette High Purity Pharmaceutical Excipient Product Portfolio Table 111. Roquette Recent Development Table 112. Seqens Company Information Table 113. Seqens Business Overview Table 114. Seqens High Purity Pharmaceutical Excipient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Seqens High Purity Pharmaceutical Excipient Product Portfolio Table 116. Seqens Recent Development Table 117. North America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 118. North America High Purity Pharmaceutical Excipient Sales by Country (2021-2026) & (Tons) Table 119. North America High Purity Pharmaceutical Excipient Sales Market Share by Country (2021-2026) Table 120. North America High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032) & (Tons) Table 121. North America High Purity Pharmaceutical Excipient Sales Market Share Forecast by Country (2027-2032) Table 122. North America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America High Purity Pharmaceutical Excipient Market Size by Country (2021-2026) & (US$ Million) Table 124. North America High Purity Pharmaceutical Excipient Market Share by Country (2021-2026) Table 125. North America High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America High Purity Pharmaceutical Excipient Market Share Forecast by Country (2027-2032) Table 127. Europe High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 128. Europe High Purity Pharmaceutical Excipient Sales by Country (2021-2026) & (Tons) Table 129. Europe High Purity Pharmaceutical Excipient Sales Market Share by Country (2021-2026) Table 130. Europe High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032) & (Tons) Table 131. Europe High Purity Pharmaceutical Excipient Sales Market Share Forecast by Country (2027-2032) Table 132. Europe High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe High Purity Pharmaceutical Excipient Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe High Purity Pharmaceutical Excipient Market Share by Country (2021-2026) Table 135. Europe High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe High Purity Pharmaceutical Excipient Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Country (2021-2026) & (Tons) Table 139. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032) & (Tons) Table 141. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific High Purity Pharmaceutical Excipient Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific High Purity Pharmaceutical Excipient Market Share by Country (2021-2026) Table 145. Asia-Pacific High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific High Purity Pharmaceutical Excipient Market Share Forecast by Country (2027-2032) Table 147. Latin America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Latin America High Purity Pharmaceutical Excipient Sales by Country (2021-2026) & (Tons) Table 149. Latin America High Purity Pharmaceutical Excipient Sales Market Share by Country (2021-2026) Table 150. Latin America High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032) & (Tons) Table 151. Latin America High Purity Pharmaceutical Excipient Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America High Purity Pharmaceutical Excipient Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America High Purity Pharmaceutical Excipient Market Share by Country (2021-2026) Table 155. Latin America High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America High Purity Pharmaceutical Excipient Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Country (2021-2026) & (Tons) Table 159. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032) & (Tons) Table 161. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa High Purity Pharmaceutical Excipient Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa High Purity Pharmaceutical Excipient Market Share by Country (2021-2026) Table 165. Middle East and Africa High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa High Purity Pharmaceutical Excipient Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. High Purity Pharmaceutical Excipient Distributors List Table 170. High Purity Pharmaceutical Excipient Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. High Purity Pharmaceutical Excipient Image Figure 2. Global High Purity Pharmaceutical Excipient Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High Purity Pharmaceutical Excipient Market Size (2021-2032) & (US$ Million) Figure 4. Global High Purity Pharmaceutical Excipient Sales (2021-2032) & (Tons) Figure 5. Natural Excipients Image Figure 6. Global Natural Excipients Sales YoY Growth (2021-2032) & (Tons) Figure 7. Semi-natural Excipients Image Figure 8. Global Semi-natural Excipients Sales YoY Growth (2021-2032) & (Tons) Figure 9. Completely Synthetic Excipients Image Figure 10. Global Completely Synthetic Excipients Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global High Purity Pharmaceutical Excipient Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global High Purity Pharmaceutical Excipient Market Share by Type 2025 VS 2032 Figure 13. North America High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type in 2025 Figure 14. North America High Purity Pharmaceutical Excipient Sales Market Share in Value by Type in 2025 Figure 15. Europe High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type in 2025 Figure 16. Europe High Purity Pharmaceutical Excipient Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share in Value by Type in 2025 Figure 19. Latin America High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type in 2025 Figure 20. Latin America High Purity Pharmaceutical Excipient Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 High Purity Pharmaceutical Excipient Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Injectable Medications Image Figure 26. Global Injectable Medications Sales YoY Growth (2021-2032) & (Tons) Figure 27. Ocular Medications Image Figure 28. Global Ocular Medications Sales YoY Growth (2021-2032) & (Tons) Figure 29. Oral Medications Image Figure 30. Global Oral Medications Sales YoY Growth (2021-2032) & (Tons) Figure 31. Medications Inhaled Through the Nose or Mouth Image Figure 32. Global Medications Inhaled Through the Nose or Mouth Sales YoY Growth (2021-2032) & (Tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 35. Global High Purity Pharmaceutical Excipient Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global High Purity Pharmaceutical Excipient Market Share by Application 2025 VS 2032 Figure 37. North America High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application in 2025 Figure 38. North America High Purity Pharmaceutical Excipient Sales Market Share in Value by Application in 2025 Figure 39. Europe High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application in 2025 Figure 40. Europe High Purity Pharmaceutical Excipient Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific High Purity Pharmaceutical Excipient Sales Market Share in Value by Application in 2025 Figure 43. Latin America High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application in 2025 Figure 44. Latin America High Purity Pharmaceutical Excipient Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa High Purity Pharmaceutical Excipient Sales Market Share in Value by Application in 2025 Figure 47. North America High Purity Pharmaceutical Excipient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. North America High Purity Pharmaceutical Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America High Purity Pharmaceutical Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America High Purity Pharmaceutical Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe High Purity Pharmaceutical Excipient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Europe High Purity Pharmaceutical Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe High Purity Pharmaceutical Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe High Purity Pharmaceutical Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific High Purity Pharmaceutical Excipient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Asia-Pacific High Purity Pharmaceutical Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific High Purity Pharmaceutical Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific High Purity Pharmaceutical Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America High Purity Pharmaceutical Excipient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Latin America High Purity Pharmaceutical Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America High Purity Pharmaceutical Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America High Purity Pharmaceutical Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa High Purity Pharmaceutical Excipient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 64. Middle East and Africa High Purity Pharmaceutical Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa High Purity Pharmaceutical Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa High Purity Pharmaceutical Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. High Purity Pharmaceutical Excipient Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. High Purity Pharmaceutical Excipient Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Excipients
  • Semi-natural Excipients
  • Completely Synthetic Excipients
Applications
  • Injectable Medications
  • Ocular Medications
  • Oral Medications
  • Medications Inhaled Through the Nose or Mouth
  • Others
Companies covered
  • Evonik
  • BASF
  • Syensqo
  • Mitsubishi
  • JRS Pharma
  • Croda Pharma
  • Ashland
  • Roquette
  • Seqens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global High Purity Pharmaceutical Excipient Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global High Purity Pharmaceutical Excipient Sales Estimates and Forecasts (2021-2032)
  5. 1.3 High Purity Pharmaceutical Excipient Market by Type
  6. 1.3.1 Natural Excipients
  7. 1.3.2 Semi-natural Excipients
  8. 1.3.3 Completely Synthetic Excipients
  9. 1.4 Global High Purity Pharmaceutical Excipient Market Size by Type
  10. 1.4.1 Global High Purity Pharmaceutical Excipient Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global High Purity Pharmaceutical Excipient Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global High Purity Pharmaceutical Excipient Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America High Purity Pharmaceutical Excipient Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe High Purity Pharmaceutical Excipient Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific High Purity Pharmaceutical Excipient Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America High Purity Pharmaceutical Excipient Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa High Purity Pharmaceutical Excipient Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 High Purity Pharmaceutical Excipient Industry Trends
  2. 2.2 High Purity Pharmaceutical Excipient Industry Drivers
  3. 2.3 High Purity Pharmaceutical Excipient Industry Opportunities and Challenges
  4. 2.4 High Purity Pharmaceutical Excipient Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by High Purity Pharmaceutical Excipient Revenue (2021-2026)
  2. 3.2 Global Top Players by High Purity Pharmaceutical Excipient Sales (2021-2026)
  3. 3.3 Global Top Players by High Purity Pharmaceutical Excipient Price (2021-2026)
  4. 3.4 Global High Purity Pharmaceutical Excipient Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global High Purity Pharmaceutical Excipient Major Company Production Sites & Headquarters
  6. 3.6 Global High Purity Pharmaceutical Excipient Company, Product Type & Application
  7. 3.7 Global High Purity Pharmaceutical Excipient Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global High Purity Pharmaceutical Excipient Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 High Purity Pharmaceutical Excipient Players Market Share by Revenue in 2025
  11. 3.8.3 2025 High Purity Pharmaceutical Excipient Tier 1, Tier 2, and Tier 3
4 High Purity Pharmaceutical Excipient Regional Status and Outlook
  1. 4.1 Global High Purity Pharmaceutical Excipient Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global High Purity Pharmaceutical Excipient Historic Market Size by Region
  3. 4.2.1 Global High Purity Pharmaceutical Excipient Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global High Purity Pharmaceutical Excipient Sales in Value by Region (2021-2026)
  5. 4.2.3 Global High Purity Pharmaceutical Excipient Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global High Purity Pharmaceutical Excipient Forecasted Market Size by Region
  7. 4.3.1 Global High Purity Pharmaceutical Excipient Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global High Purity Pharmaceutical Excipient Sales in Value by Region (2027-2032)
  9. 4.3.3 Global High Purity Pharmaceutical Excipient Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 High Purity Pharmaceutical Excipient by Application
  1. 5.1 High Purity Pharmaceutical Excipient Market by Application
  2. 5.1.1 Injectable Medications
  3. 5.1.2 Ocular Medications
  4. 5.1.3 Oral Medications
  5. 5.1.4 Medications Inhaled Through the Nose or Mouth
  6. 5.1.5 Others
  7. 5.2 Global High Purity Pharmaceutical Excipient Market Size by Application
  8. 5.2.1 Global High Purity Pharmaceutical Excipient Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global High Purity Pharmaceutical Excipient Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global High Purity Pharmaceutical Excipient Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America High Purity Pharmaceutical Excipient Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe High Purity Pharmaceutical Excipient Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific High Purity Pharmaceutical Excipient Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America High Purity Pharmaceutical Excipient Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa High Purity Pharmaceutical Excipient Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Evonik
  2. 6.1.1 Evonik Company Information
  3. 6.1.2 Evonik Business Overview
  4. 6.1.3 Evonik High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Evonik High Purity Pharmaceutical Excipient Product Portfolio
  6. 6.1.5 Evonik Recent Developments
  7. 6.2 BASF
  8. 6.2.1 BASF Company Information
  9. 6.2.2 BASF Business Overview
  10. 6.2.3 BASF High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BASF High Purity Pharmaceutical Excipient Product Portfolio
  12. 6.2.5 BASF Recent Developments
  13. 6.3 Syensqo
  14. 6.3.1 Syensqo Company Information
  15. 6.3.2 Syensqo Business Overview
  16. 6.3.3 Syensqo High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Syensqo High Purity Pharmaceutical Excipient Product Portfolio
  18. 6.3.5 Syensqo Recent Developments
  19. 6.4 Mitsubishi
  20. 6.4.1 Mitsubishi Company Information
  21. 6.4.2 Mitsubishi Business Overview
  22. 6.4.3 Mitsubishi High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mitsubishi High Purity Pharmaceutical Excipient Product Portfolio
  24. 6.4.5 Mitsubishi Recent Developments
  25. 6.5 JRS Pharma
  26. 6.5.1 JRS Pharma Company Information
  27. 6.5.2 JRS Pharma Business Overview
  28. 6.5.3 JRS Pharma High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JRS Pharma High Purity Pharmaceutical Excipient Product Portfolio
  30. 6.5.5 JRS Pharma Recent Developments
  31. 6.6 Croda Pharma
  32. 6.6.1 Croda Pharma Company Information
  33. 6.6.2 Croda Pharma Business Overview
  34. 6.6.3 Croda Pharma High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Croda Pharma High Purity Pharmaceutical Excipient Product Portfolio
  36. 6.6.5 Croda Pharma Recent Developments
  37. 6.7 Ashland
  38. 6.7.1 Ashland Company Information
  39. 6.7.2 Ashland Business Overview
  40. 6.7.3 Ashland High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ashland High Purity Pharmaceutical Excipient Product Portfolio
  42. 6.7.5 Ashland Recent Developments
  43. 6.8 Roquette
  44. 6.8.1 Roquette Company Information
  45. 6.8.2 Roquette Business Overview
  46. 6.8.3 Roquette High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roquette High Purity Pharmaceutical Excipient Product Portfolio
  48. 6.8.5 Roquette Recent Developments
  49. 6.9 Seqens
  50. 6.9.1 Seqens Company Information
  51. 6.9.2 Seqens Business Overview
  52. 6.9.3 Seqens High Purity Pharmaceutical Excipient Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Seqens High Purity Pharmaceutical Excipient Product Portfolio
  54. 6.9.5 Seqens Recent Developments
7 North America by Country
  1. 7.1 North America High Purity Pharmaceutical Excipient Sales by Country
  2. 7.1.1 North America High Purity Pharmaceutical Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America High Purity Pharmaceutical Excipient Sales by Country (2021-2026)
  4. 7.1.3 North America High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032)
  5. 7.2 North America High Purity Pharmaceutical Excipient Market Size by Country
  6. 7.2.1 North America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America High Purity Pharmaceutical Excipient Market Size by Country (2021-2026)
  8. 7.2.3 North America High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe High Purity Pharmaceutical Excipient Sales by Country
  2. 8.1.1 Europe High Purity Pharmaceutical Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe High Purity Pharmaceutical Excipient Sales by Country (2021-2026)
  4. 8.1.3 Europe High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032)
  5. 8.2 Europe High Purity Pharmaceutical Excipient Market Size by Country
  6. 8.2.1 Europe High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe High Purity Pharmaceutical Excipient Market Size by Country (2021-2026)
  8. 8.2.3 Europe High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific High Purity Pharmaceutical Excipient Sales by Country
  2. 9.1.1 Asia-Pacific High Purity Pharmaceutical Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific High Purity Pharmaceutical Excipient Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific High Purity Pharmaceutical Excipient Market Size by Country
  6. 9.2.1 Asia-Pacific High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific High Purity Pharmaceutical Excipient Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America High Purity Pharmaceutical Excipient Sales by Country
  2. 10.1.1 South America High Purity Pharmaceutical Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America High Purity Pharmaceutical Excipient Sales by Country (2021-2026)
  4. 10.1.3 South America High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032)
  5. 10.2 South America High Purity Pharmaceutical Excipient Market Size by Country
  6. 10.2.1 South America High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America High Purity Pharmaceutical Excipient Market Size by Country (2021-2026)
  8. 10.2.3 South America High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa High Purity Pharmaceutical Excipient Sales by Country
  2. 11.1.1 Middle East and Africa High Purity Pharmaceutical Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa High Purity Pharmaceutical Excipient Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa High Purity Pharmaceutical Excipient Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa High Purity Pharmaceutical Excipient Market Size by Country
  6. 11.2.1 Middle East and Africa High Purity Pharmaceutical Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa High Purity Pharmaceutical Excipient Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa High Purity Pharmaceutical Excipient Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 High Purity Pharmaceutical Excipient Value Chain Analysis
  2. 12.1.1 High Purity Pharmaceutical Excipient Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 High Purity Pharmaceutical Excipient Production Mode & Process
  7. 12.2 High Purity Pharmaceutical Excipient Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 High Purity Pharmaceutical Excipient Distributors
  10. 12.2.3 High Purity Pharmaceutical Excipient Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst